零售药店兼并重组获政策支持

Core Viewpoint - The Ministry of Commerce and nine other departments have jointly issued opinions to promote high-quality development in the pharmaceutical retail industry, focusing on five key measures [1]. Group 1: Key Measures - The five key measures include improving pharmaceutical services, innovating health services, strengthening emergency services, optimizing industry structure, and regulating industry order [1]. Group 2: Industry Structure Optimization - The opinions support the merger and reorganization of retail pharmacies, encouraging horizontal mergers and acquisitions among pharmaceutical retail enterprises [1]. - Local governments are encouraged to optimize the business environment, particularly for integrated chain or standalone pharmacies, by streamlining the application process for pharmaceutical business licenses [1]. - For changes in medical insurance qualifications, the original qualifications are allowed to continue and be used until the new qualifications are officially opened, at which point the original qualifications can be canceled [1]. Group 3: Industry Transformation - The pharmaceutical retail industry in China is at a critical stage of innovative transformation, requiring a shift from traditional drug sales to comprehensive health services, enhancing professional services, health promotion, and emergency supply capabilities [1].